PeerVoice Oncology & Haematology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 19m. Bisher sind 234 Folge(n) erschienen. Jede Woche gibt es eine neue Folge dieses Podcasts.

Gesamtlänge aller Episoden: 4 days 11 minutes

subscribe
share





share







 2014-12-10  20m
 
 

Insights and Strategies for Individualising Therapy for ALK-Positive NSCLC: Updates From Recent Medical Congresses


Go online to www.peervoice.com/h/pvs65 to view the entire programme with slides.


share







 2014-12-08  23m
 
 

Breakthroughs and Game-Changers in NSCLC Management: Expert Perspectives on Current Evidence and Practice


Go online to www.peervoice.com/h/pve60 to view the entire programme with slides.


share







 2014-12-05  29m
 
 
share







 2014-11-24  17m
 
 

Can We Accelerate Advances in Pancreatic Cancer? Applying Today's Best Evidence to Improve the Potential for Tomorrow


Go online to www.peervoice.com/h/pve59 to view the entire programme with slides.


share







 2014-11-17  22m
 
 

Pharmacologists and Oncologists Working Together to Define the Role of Biosimilars in Clinical Practice


Go online to www.peervoice.com/h/pvr154 to view the entire programme with slides.


share







 2014-11-12  47m
 
 
share







 2014-10-29  26m
 
 

Second-Line Treatment Options for Advanced Lung Adenocarcinoma: Data-Driven Decision-Making


Go online to www.peervoice.com/h/pve47 to view the entire programme with slides.


share







 2014-10-10  20m
 
 

From Bench to Bedside: Updates in the Management of Haematologic Malignancies


From Bench to Bedside: Updates in the Management of Haematologic Malignancies


share







 2014-10-08  52m
 
 

Management of Patients With Untreated AML Ineligible for Intensive Remission Induction Therapy: Challenges and Opportunities


Go online to www.peervoice.com/h/pve52 to view the entire programme with slides.


share







 2014-09-26  19m